IL6 and idiopathic pulmonary fibrosis: These cells exhibit heightened inflammatory cytokine production (e.g., IL-6, TNF-α) and impaired phagocytosis, leading to prolonged immune activation [25] Furthermore, there is evidence that aging-associated immune dysregulation including senescence and chronic low-grade inflammation may contribute to the persistence of fibrosis in IPF [26].